Daily non-political popular news in brief.

Rhode Island Hospital study confirms RF ablation effective for treating inoperable lung cancer

The overall results of a study of 153 patients with inoperable lung cancer show RF ablation to be safe and linked it with promising long-term survival and local tumor progression outcomes when compared to the older treatment method of external beam radiation (EBT). The study appears in the April issue of the journal Radiology.

Read more »

Keywords: rhode, island, hospital, study, confirms, ablation, effective, treating, inoperable, lung, cancer, confirm

« Previous | Next »

Similar news on "Rhode Island Hospital study confirms RF ablation effective for treating inoperable lung cancer":

1. Radiofrequency ablation effective treatment for inoperable lung cancer
   03-27-2007 · EurekAlert!
   Lung cancer patients who are not candidates for surgery now have another safe and effective treatment option: radiofrequency (RF) ablation, according to a new study published in the April issue of the journal Radiology.
   Similar news · Read more »
   
2. Unique estrogen receptor linked to metastatic breast cancer
   11-01-2006 · EurekAlert!
   Breast cancer awareness month may have passed, but researchers remain focused on the disease with a new study showing that a unique estrogen receptor found in breast cancer tumors is a predictor of tumor size and metastases. The study, led by researchers at Rhode Island Hospital and Brown Medical School, is published in the Nov. 1 issue of Clinical Cancer Research.
   Similar news · Read more »
   
3. Ablation procedure proves safe, effective and fast
   06-28-2007 · EurekAlert!
   Multiple-electrode radiofrequency ablation is a safe and effective way of treating patients with liver cancer that can be completed in less time than current ablation techniques, according to a recent study conducted by researchers at the University of Wisconsin in Madison.
   Similar news · Read more »
   
4. Rhode Island Hospital news tips from Radiological Society of North America 2007 annual meeting
   11-29-2007 · EurekAlert!
   Rhode Island Hospital radiologists present innovative research on adrenal masses and CT scans, radiofrequency ablation and kidney tumors, and microwave ablation and lung tumors at the Radiological Society of North America 2007 annual meeting Nov. 25-30, 2007 in Chicago, Ill.
   Similar news · Read more »
   
5. Jefferson oncologists show focused radiation is effective as surgery against nerve tumor
   10-30-2007 · EurekAlert!
   Specifically aimed, "stereotactic" radiation may be as good as surgery -- and in some cases, even better -- in treating benign but potentially devastating brain tumors called nonacoustic schwannomas, according to a study by rradiation oncologists at the Kimmel Cancer Center at Thomas Jefferson University and Thomas Jefferson University Hospital in Philadelphia.
   Similar news · Read more »
   
6. Studies led by Rhode Island Hospital confirm safety and efficacy
   11-17-2006 · EurekAlert!
   Following two studies of patients who were treated with cardiac stents, physicians at Rhode Island Hospital continue to recommend drug-eluting stents as a safe and effective treatment.
   Similar news · Read more »
   
7. Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer
   11-01-2007 · EurekAlert!
   A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.
   Similar news · Read more »
   
8. Cisplatin is more effective than carboplatin for treating nonsmall cell lung cancer
   06-05-2007 · EurekAlert!
   Some patients with advanced nonsmall cell lung cancer have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug, carboplatin, according to a study in the June 6 Journal of the National Cancer Institute. The authors conclude that cisplatin chemotherapy should remain the standard of care for these patients.
   Similar news · Read more »
   
9. Novel EGFR ectodomain mutations in glioblastoma
   12-18-2006 · EurekAlert!
   The Epidermal Growth Factor Receptor, a so-called kinase protein, is often abnormally active in cancer. A new class of anticancer drugs inhibiting the activated EGFR kinase have shown to be effective against such cancers, especially lung cancer. In a new study in PLoS Medicine, researchers have catalogued and characterized the mutations in the EGFR gene that occur in glioblastoma, a deadly type of brain tumor.
   Similar news · Read more »
   
10. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
    06-15-2007 · EurekAlert!
    Current cancer therapies often are thwarted because they cannot eliminate a small reservoir of multiple-drug-resistant tumor cells. Researchers at the University of Pittsburgh School of Medicine suggests that for chemotherapy to be truly effective in treating lung cancers, for example, it must be able to target a small subset of cancer stem cells, which they have shown share the same protective mechanisms as normal lung stem cells.
    Similar news · Read more »